Single-agent interferon alfa produces response rates similar to those of standard chemotherapy in low-grade lymphomas. Interferon has been combined with, or used as, maintenance therapy for these diseases. Most studies have demonstrated improvement in disease-free survival rates, and some patients have improved survival when interferon is added to initial regimens.
Sarah J. Thompson, MD
Online Diagnosis of Symptoms and Medical Diseases
Online Diagnosis of Psychiatric Disorders